Henders Land Dev (HKG:12)

newratings.com  4 hrs ago  Comment 
AMSTERDAM (dpa-AFX) - The Netherlands' economic growth held steady in the three months ended June as initially estimated, latest data from the Central Bureau of Statistics showed Friday. Gross domestic product rose at a stable pace of 0.6...
The Economic Times  6 hrs ago  Comment 
The Rs 900 crore IPO issue was subscribed 2.53 times. The IPO was sold in the price band of Rs 850-860 between September 12 and September 15.
Benzinga  Sep 22  Comment 
$30.49 - September 12 close $30.11 - Intraday high as of 3:25 PM $30.05 - Current price as of 3:25 PM $29.93 - Intraday low as of 3:25 PM $29.85 - Wednesday close If content like this is useful to your trading/investing...
The Hindu Business Line  Sep 22  Comment 
The short-term outlook for the stock of HCL Infosystems has turned bullish. The stock skyrocketed 12 per cent of Thursday breaking above the 200-day moving average as well as a resistance at ₹46. Th...
Clusterstock  Sep 22  Comment 
Every year since 2009, the staff at Motor Trend magazine along with professional racer Randy Pobst have selected what they consider to be the Best Driver's Car of the Year.  Past winners of the competition include the Chevrolet Camaro Z/28,...
newratings.com  Sep 22  Comment 
PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) announced SD-809 (deutetrabenazine) showed statistically significant results in the second Phase III registration trial studying the potential of SD-809 for the treatment of...
New York Times  Sep 22  Comment 
Xia Lin, a Beijing rights lawyer, called the case part of China’s campaign to silence lawyers who have challenged arbitrary state power.
Benzinga  Sep 21  Comment 
Shares of Pure Storage Inc (NYSE: PSTG) have gained more than 11 percent since September 12. Nonetheless, the Vetr crowd seems to believe the rally will continue, as evidenced by its average price target of $14.72. This target implies a potential...
Benzinga  Sep 21  Comment 
  Mast Therapeutics Inc (NYSE: MSTX) shares tumbled 80.3 percent to $0.116 after the company announced its phase-3 EPIC trial of vepoloxamer for the treatment of sickle cell disease patients experiencing vaso-occlusive crisis failed to meet...
Motley Fool  Sep 21  Comment 
These companies are showing healthier sales and profit growth than the struggling cybersecurity specialist.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki